advertisement
Reply
 
Thread Tools Display Modes
Old 08-25-2017, 02:00 AM #1
NewsBot NewsBot is offline
News Gatherer
Community Support Team
 
Join Date: Dec 2007
Posts: 65,355
15 yr Member
NewsBot NewsBot is offline
News Gatherer
Community Support Team
 
Join Date: Dec 2007
Posts: 65,355
15 yr Member
Post Adamas Pharma shares soar on Parkinson's dyskinesia drug approval - MarketWatch


Smarter Analyst


Adamas Pharma shares soar on Parkinson's dyskinesia drug approval
MarketWatch
Adamas Pharmaceuticals Inc. ADMS, -1.11% shares soared after the drug maker received Food and Drug Administration approval for a one-of-a-kind treatment for the involuntary movements associated with Parkinson's disease. Adamas shares jumped 36% ...
Adamas Pharma secures approval for Parkinson's dyskinesia drugReuters
Adamas wins its first FDA OK, setting up market launch for a ...Endpoints News
ADMS Soars On FDA Nod, EARS Gets An Earful, Thumbs Up For BIIB's Humira BiosimMarkets Insider
StreetInsider.com -Smarter Analyst -MD Magazine (registration) (blog)
all 9 news articles »


More...
NewsBot is offline   Reply With QuoteReply With Quote

advertisement
Reply

Tags
adamas, drug, shares, approval, parkinson's


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On



All times are GMT -5. The time now is 06:49 PM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.